세계의 동물용 POC 진단 시장 보고서(2025년)
Veterinary Point Of Care Diagnostics Global Market Report 2025
상품코드 : 1793381
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,527,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,434,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,341,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

동물용 POC 진단 시장 규모는 앞으로 몇 년 동안 급성장할 것으로 예측됩니다. 2029년에는 연평균 복합 성장률(CAGR) 13.4%를 나타내 33억 1,000만 달러로 성장할 전망입니다. 예측기간의 성장은 반려동물 수 증가, 예방 헬스케어의 중시, 원격지나 농촌에서의 액세스 요구, 개별화된 수의학, 세계의 건강에의 대비 등에 기인하는 것으로 예측됩니다. 예측기간의 주요 동향으로는 기술의 진보, 제품의 혁신, 재택검사에 대한 소비자의 기호 등이 있습니다.

향후 5년간의 성장률 13.4%라고 하는 예측은 전회의 예측으로부터 0.1%의 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세로 인한 휴대용 검사 장비 및 카트리지의 비용 상승은 원격지에서의 POC 진단 시장 침투를 방해할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

반려동물의 인구 증가는 동물용 POC 진단 시장 성장을 가속합니다. 반려동물은 반려동물로 인간과 거주 공간을 동거시키는 동물이며, 증가하는 경향이 있습니다. 이 반려동물 인구 증가는 진단, 치료 선택, 모니터링 및 예후의 신속한 임상 결정을 촉진하고 동물용 POC 진단에 대한 수요를 부추깁니다. 또한 업무상의 의사결정과 자원 활용에도 도움이 됩니다. 미국 반려동물용품협회(American Pet Products Association)의 2021-2022년 전국 반려동물소유자조사(National Pet Owners Survey)에서 강조된 바와 같이, 현재 미국 전체 가구의 70%가 반려동물을 기르고 있습니다. 이 반려동물의 상당한 증가는 동물용 POC 진단 시장 성장에 크게 기여합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Veterinary point-of-care diagnostics play a vital role in real-time animal health assessment, delivering clinically relevant information during clinical practice without relying on laboratory results. This approach significantly reduces the turnaround time (TAT) for animal test results, aiding clinicians in promptly determining the appropriate treatment course for their patients.

The primary products within veterinary point-of-care diagnostics include consumables, reagents, kits, instruments, and devices. Consumables, reagents, and kits are utilized in the diagnosis of infectious and metabolic diseases in both companion and livestock animals. These products encompass substances consumed during testing, materials for preparing diagnostic products, and test kits used in various diagnostic technologies such as immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, urinalysis, and other related technologies. Veterinary point-of-care diagnostics find application in veterinary clinics, hospitals, academic institutes, and even home care settings for the benefit of animal health.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The veterinary point of care diagnostics market research report is one of a series of new reports from The Business Research Company that provides veterinary point of care diagnostics market statistics, including veterinary point of care diagnostics industry global market size, regional shares, competitors with a veterinary point of care diagnostics market share, detailed veterinary point of care diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary point of care diagnostics industry. This veterinary point of care diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary point of care diagnostics market size has grown rapidly in recent years. It will grow from $1.78 billion in 2024 to $2.01 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to education and awareness programs, integration with telemedicine, focus on infectious disease control, regulatory support and approvals, livestock and production animal management.

The veterinary point of care diagnostics market size is expected to see rapid growth in the next few years. It will grow to $3.31 billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing pet population, preventive healthcare emphasis, remote and rural access needs, personalized veterinary medicine, global health preparedness. Major trends in the forecast period include technological advancements, product innovations, consumer preference for home testing.

The forecast of 13.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Higher costs of portable testing devices and cartridges due to tariffs may hinder market penetration of point-of-care diagnostics in remote areas. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The expanding population of companion animals is poised to drive the growth of the veterinary point-of-care diagnostics market. Companion animals, which cohabit residential spaces with humans as pets, are on the rise. This uptick in the companion animal population is fueling the demand for veterinary point-of-care diagnostics, facilitating swift clinical decision-making in diagnostics, treatment selection, monitoring, and prognosis. It also aids in operational decision-making and resource utilization. As highlighted by the American Pet Products Association's 2021-2022 National Pet Owners Survey, 70% of all US households now have a companion animal. This substantial increase in companion animals contributes significantly to the growth of the veterinary point-of-care diagnostics market.

The increasing prevalence of dermatological diseases is anticipated to be a key driver for the growth of the veterinary point-of-care diagnostics market. Dermatological diseases, encompassing a range of skin-related medical conditions, require early detection and treatment. With a rising pet population and evolving ownership trends, there is a growing demand for immediate and on-site skin evaluations. Point-of-care diagnostics play a crucial role by offering diverse tests for comprehensive dermatological assessments, supporting preventive care, and meeting client expectations for timely diagnostics. An example of this trend is the surge in cases of Lumpy Skin Disease in India, affecting over 2.4 million animals and resulting in the death of more than 110,000 cattle as of October 2022. This heightened burden of dermatological diseases is a significant factor driving the growth of the veterinary point-of-care diagnostics market.

Major companies in the veterinary point-of-care diagnostics market are actively developing new veterinary analyzers to fortify their market positions. A case in point is Chengdu Seamaty Technology Co., Ltd., a China-based medical equipment manufacturing company, which, in August 2023, launched four innovative veterinary analyzers tailored for pet hospitals. These analyzers, including the VG2 Vet Blood Gas Electrolyte Immunoassay Analyzer, VG1 Veterinary Blood Gas & Electrolyte Analyzer, Vi1 Veterinary Fluorescence Immunoassay Analyzer, and VBC30/VBC50 Hematology Analyzers, provide rapid and precise diagnostic insights for diseases, immunity assessment, and inflammation monitoring in canines and felines. With user-friendly interfaces and portable designs, these analyzers seamlessly integrate into veterinary workflows, enhancing efficiency and enabling immediate decision-making for optimal patient care.

Major players in the veterinary point-of-care diagnostics market are actively developing new assays as part of their strategy to gain a competitive advantage. Assays, which are diagnostic procedures or tests designed to detect specific biological markers, substances, or conditions associated with particular diseases or health conditions, are pivotal in advancing diagnostic capabilities. For example, in September 2023, Zomedica Corp., a prominent US-based veterinary health company, launched a new assay called endogenous ACTH (eACTH) for equine plasma. This assay is incorporated into Zomedica's TRUFORMA In-Clinic Biosensor Testing Platform, enabling equine veterinarians to conveniently diagnose and manage Cushing's Disease (pituitary pars intermedia dysfunction - PPID) directly at the clinic or stall. The eACTH assay delivers reference lab accuracy, supporting the diagnosis and monitoring of horses with PPID, a prevalent endocrine disorder in equines. Zomedica's focus on catering to the unique needs of equine practitioners highlights its commitment to enhancing both patient and practice health through the TRUFORMA diagnostic platform.

In March 2022, Vimian Group, a Sweden-based veterinary company, made a strategic move by acquiring Avacta Animal Health, the veterinary allergy division of Avacta Group PLC., for an undisclosed amount. This acquisition was a targeted effort by Vimian Group to reinforce its position in veterinary allergy diagnostics and treatments, specifically within the UK market. Avacta Group PLC, based in the UK, is a provider of diagnostic tools utilized in both human and animal healthcare. This strategic acquisition aligns with Vimian Group's broader objectives to strengthen its capabilities and offerings in the field of veterinary diagnostics, especially in the area of allergy-related diagnostics and treatments.

Major companies operating in the veterinary point of care diagnostics market are Zoetis Inc., IDEXX Laboratories Inc., Heska Corporation, Virbac Animal Health India Pvt Ltd, Eurolyser Diagnostica GmbH, Randox Laboratories Ltd, Anipoc Ltd, Neogen Corporation, Abaxis Inc., Alvedia, bioMerieux SA, Bionote Inc., Clindiag Systems Co. Ltd., Coris BioConcept, Creative Diagnostics, DiaSys Diagnostic Systems GmbH, Eiken Chemical Co. Ltd., Gold Standard Diagnostics Corp., Hangzhou AllTest Biotech Co. Ltd., InBios International Inc.

North America was the largest region in the veterinary point of care diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary point of care diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary point of care diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary point-of-care diagnostics market includes revenues earned by entities by hematology, diagnostic imaging, bacteriology, virology, cytology, clinical chemistry and parasitology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Point Of Care Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary point of care diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for veterinary point of care diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary point of care diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Veterinary Point Of Care Diagnostics Market Characteristics

3. Veterinary Point Of Care Diagnostics Market Trends And Strategies

4. Veterinary Point Of Care Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Veterinary Point Of Care Diagnostics Growth Analysis And Strategic Analysis Framework

6. Veterinary Point Of Care Diagnostics Market Segmentation

7. Veterinary Point Of Care Diagnostics Market Regional And Country Analysis

8. Asia-Pacific Veterinary Point Of Care Diagnostics Market

9. China Veterinary Point Of Care Diagnostics Market

10. India Veterinary Point Of Care Diagnostics Market

11. Japan Veterinary Point Of Care Diagnostics Market

12. Australia Veterinary Point Of Care Diagnostics Market

13. Indonesia Veterinary Point Of Care Diagnostics Market

14. South Korea Veterinary Point Of Care Diagnostics Market

15. Western Europe Veterinary Point Of Care Diagnostics Market

16. UK Veterinary Point Of Care Diagnostics Market

17. Germany Veterinary Point Of Care Diagnostics Market

18. France Veterinary Point Of Care Diagnostics Market

19. Italy Veterinary Point Of Care Diagnostics Market

20. Spain Veterinary Point Of Care Diagnostics Market

21. Eastern Europe Veterinary Point Of Care Diagnostics Market

22. Russia Veterinary Point Of Care Diagnostics Market

23. North America Veterinary Point Of Care Diagnostics Market

24. USA Veterinary Point Of Care Diagnostics Market

25. Canada Veterinary Point Of Care Diagnostics Market

26. South America Veterinary Point Of Care Diagnostics Market

27. Brazil Veterinary Point Of Care Diagnostics Market

28. Middle East Veterinary Point Of Care Diagnostics Market

29. Africa Veterinary Point Of Care Diagnostics Market

30. Veterinary Point Of Care Diagnostics Market Competitive Landscape And Company Profiles

31. Veterinary Point Of Care Diagnostics Market Other Major And Innovative Companies

32. Global Veterinary Point Of Care Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Point Of Care Diagnostics Market

34. Recent Developments In The Veterinary Point Of Care Diagnostics Market

35. Veterinary Point Of Care Diagnostics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기